SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTSL.L Regulatory News (TSL)

  • There is currently no data for TSL

Rule 8.3- Tissue Science

14 Mar 2008 16:31

Lady Margaret Ruth Elliot14 March 2008 FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the Takeover Code) 1. KEY INFORMATION Name of person dealing (Note 1) ADAM & COMPANY (NOMINEES) LIMITED FOR LADY MARGARET RUTH ELLIOT Company dealt in TISSUE SCIENCE LABORATORIES PLC Class of relevant security to which ORDINARY 10P SHARES the dealings being disclosed relate (Note 2) Date of dealing 13 MARCH 2008 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevantsecurity dealt in (Note 3) Long Short Number (%) Number (%) (1) Relevant securities 0 (0.00) 0 (0.00) (2) Derivatives (other than options) 0 (0.00) 0 (0.00) (3) Options and agreements to 0 (0.00) 0 (0.00) purchase/sell Total 0 (0.00) 0 (0.00) (b) Interests and short positions in relevant securities of the company, otherthan the class dealt in (Note 3) Class of relevant security: Long Short Number (%) Number (%) (1) Relevant securities (2) Derivatives (other than options) (3) Options and agreements to purchase/sell Total (c) Rights to subscribe (Note 3) Class of relevant security: Details 3. DEALINGS (Note 4) (a) Purchases and sales Purchase/sale Number of securities Price per unit (Note 5) SALE 465,909 £1.015 GBP (b) Derivatives transactions (other than options) Product Long/short Number of Price per name, e.g. (Note 6) securities unit (Note 5)CFD (Note 7) (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product Writing, Number of Exercise Type, Expiry Option name,e.g. selling, securities price e.g. date money call purchasing, to which American, paid/ option varying the option European received etc. relates etc. per unit (Note 7) (Note 5) (ii) Exercising Product name, Number of Exercise price per unit e.g. call option securities (Note 5) (d) Other dealings (including new securities) (Note 4) Nature of transaction Details Price per unit (Note 8) (if applicable) (Note 5) 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the persondisclosing and any other person relating to the voting rights of any relevantsecurities under any option referred to on this form or relating to the votingrights or future acquisition or disposal of any relevant securities to which anyderivative referred to on this form is referenced. If none, this should bestated. .............................................................................. Is a Supplemental Form 8 attached? (Note 9) NO Date of disclosure 14 MARCH 2008 Contact name COLIN MOFFAT Telephone number 0131 777 1771 If a connected EFM, name of offeree /offeror with which connected If a connected EFM, state nature of connection (Note 10) Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
11th Nov 20202:57 pmRNSResults of Annual General Meeting
11th Nov 20207:00 amRNS2020 AGM Statement and Business Update
10th Nov 202011:05 amRNSSecond Price Monitoring Extn
10th Nov 202011:00 amRNSPrice Monitoring Extension
5th Nov 202012:10 pmRNS2020 Annual General Meeting to be virtual only
28th Oct 20201:16 pmRNSHolding(s) in Company
26th Oct 20202:06 pmRNSSecond Price Monitoring Extn
26th Oct 20202:01 pmRNSPrice Monitoring Extension
26th Oct 20209:00 amRNSPrice Monitoring Extension
19th Oct 20204:41 pmRNSSecond Price Monitoring Extn
19th Oct 20204:36 pmRNSPrice Monitoring Extension
15th Oct 202011:00 amRNSCapital Return and Dividend and Notice of AGM
21st Sep 202011:05 amRNSSecond Price Monitoring Extn
21st Sep 202011:00 amRNSPrice Monitoring Extension
17th Sep 20204:36 pmRNSPrice Monitoring Extension
17th Sep 20202:05 pmRNSSecond Price Monitoring Extn
17th Sep 20202:00 pmRNSPrice Monitoring Extension
17th Sep 20207:00 amRNSResults for the year ended 30 June 2020
4th Sep 20201:05 pmRNSNotice of Final Results
3rd Sep 20202:05 pmRNSSecond Price Monitoring Extn
3rd Sep 20202:00 pmRNSPrice Monitoring Extension
14th Aug 20204:41 pmRNSSecond Price Monitoring Extn
14th Aug 20204:36 pmRNSPrice Monitoring Extension
12th Aug 20203:02 pmRNSHolding(s) in Company
12th Aug 202012:06 pmRNSHolding(s) in Company
10th Aug 20202:06 pmRNSSecond Price Monitoring Extn
10th Aug 20202:01 pmRNSPrice Monitoring Extension
10th Aug 20207:00 amRNSSettlement of legal proceedings
6th Jul 202010:00 amRNSDirector/PDMR Shareholding
1st Jul 202011:40 amRNSHolding(s) in Company
29th Jun 202011:40 amRNSPDMR Shareholding Notification
29th Jun 20207:00 amRNSPDMR Shareholding Notification
23rd Jun 20201:20 pmRNSHolding(s) in Company
23rd Jun 202010:22 amRNSClearpay Trading Update
22nd Jun 202010:20 amRNSHolding(s) in Company
19th Jun 202010:15 amRNSHolding(s) in Company
17th Jun 202010:06 amRNSHolding(s) in Company
17th Jun 202010:05 amRNSHolding(s) in Company
14th May 202011:25 amRNSHolding(s) in Company
13th May 202012:09 pmRNSHolding(s) in Company
13th May 20209:50 amRNSDirector/PDMR Shareholding
12th May 202011:06 amRNSSecond Price Monitoring Extn
12th May 202011:00 amRNSPrice Monitoring Extension
11th May 20209:40 amRNSBoard Change
7th May 20209:30 amRNSDirector/PDMR Shareholding
5th May 202011:05 amRNSDirector/PDMR Shareholding
4th Mar 20207:00 amRNSInterim Results for 6 month ended 31 Dec 2019
2nd Dec 20192:06 pmRNSSecond Price Monitoring Extn
2nd Dec 20192:00 pmRNSPrice Monitoring Extension
29th Nov 201911:50 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.